$1.70
5.31% today
NYSE, Apr 03, 07:20 pm CET
ISIN
US67080N1019
Symbol
NUVB
Sector
Industry

Nuvation Bio Inc - Ordinary Shares - Class A Target price 2025 - Analyst rating & recommendation

Nuvation Bio Inc - Ordinary Shares - Class A Classifications & Recommendation:

Buy
100%

Nuvation Bio Inc - Ordinary Shares - Class A Price Target

Target Price $7.67
Price $1.79
Potential
Number of Estimates 6
6 Analysts have issued a price target Nuvation Bio Inc - Ordinary Shares - Class A 2026 . The average Nuvation Bio Inc - Ordinary Shares - Class A target price is $7.67. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 7 analysts: 7 Analysts recommend Nuvation Bio Inc - Ordinary Shares - Class A to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Nuvation Bio Inc - Ordinary Shares - Class A stock has an average upside potential 2026 of . Most analysts recommend the Nuvation Bio Inc - Ordinary Shares - Class A stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 7.87 33.49
325.60%
Net Margin -9,057.72% -669.41%
92.61%

7 Analysts have issued a sales forecast Nuvation Bio Inc - Ordinary Shares - Class A 2025 . The average Nuvation Bio Inc - Ordinary Shares - Class A sales estimate is

$33.5m
Unlock
. This is
325.60% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$153m 1,845.36%
Unlock
, the lowest is
$5.5m 30.11%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $7.9m
2025
$33.5m 325.60%
Unlock
2026
$63.2m 88.57%
Unlock
2027
$151m 139.48%
Unlock
2028
$234m 54.40%
Unlock
2029
$386m 65.48%
Unlock

4 Nuvation Bio Inc - Ordinary Shares - Class A Analysts have issued a net profit forecast 2025. The average Nuvation Bio Inc - Ordinary Shares - Class A net profit estimate is

$-224m
Unlock
. This is
70.50% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-203m 73.33%
Unlock
, the lowest is
$-248m 67.35%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-713m 502.86%
2025
$-224m 68.55%
Unlock
2026
$-239m 6.39%
Unlock
2027
$-207m 13.14%
Unlock
2028
$-160m 22.56%
Unlock
2029
$-108m 32.63%
Unlock

Net Margin

2024 -9,057.72%
2025
-669.41% 92.61%
Unlock
2026
-377.70% 43.58%
Unlock
2027
-136.99% 63.73%
Unlock
2028
-68.72% 49.84%
Unlock
2029
-27.97% 59.30%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -2.11 -0.66
502.86% 68.72%
P/E negative
EV/Sales 3.36

4 Analysts have issued a Nuvation Bio Inc - Ordinary Shares - Class A forecast for earnings per share. The average Nuvation Bio Inc - Ordinary Shares - Class A EPS is

$-0.66
Unlock
. This is
70.67% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.60 73.33%
Unlock
, the lowest is
$-0.73 67.56%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-2.11 502.86%
2025
$-0.66 68.72%
Unlock
2026
$-0.71 7.58%
Unlock
2027
$-0.61 14.08%
Unlock
2028
$-0.48 21.31%
Unlock
2029
$-0.32 33.33%
Unlock

P/E ratio

Current -0.79 92.48%
2025
-2.70 241.77%
Unlock
2026
-2.54 5.93%
Unlock
2027
-2.92 14.96%
Unlock
2028
-3.77 29.11%
Unlock
2029
-5.59 48.28%
Unlock

Based on analysts' sales estimates for 2025, the Nuvation Bio Inc - Ordinary Shares - Class A stock is valued at an EV/Sales of

and an P/S ratio of
18.10
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 14.29
2025
3.36 76.50%
Unlock
2026
1.78 46.97%
Unlock
2027
0.74 58.24%
Unlock
2028
0.48 35.23%
Unlock
2029
0.29 39.58%
Unlock

P/S ratio

Current
2025
18.10 76.50%
Unlock
2026
9.60 46.97%
Unlock
2027
4.01 58.24%
Unlock
2028
2.60 35.23%
Unlock
2029
1.57 39.57%
Unlock

Current Nuvation Bio Inc - Ordinary Shares - Class A Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Jones Trading
Locked
Locked
Locked Mar 12 2025
HC Wainwright & Co.
Locked
Locked
Locked Mar 10 2025
HC Wainwright & Co.
Locked
Locked
Locked Jan 23 2025
HC Wainwright & Co.
Locked
Locked
Locked Jan 22 2025
RBC Capital
Locked
Locked
Locked Jan 07 2025
HC Wainwright & Co.
Locked
Locked
Locked Jan 06 2025
RBC Capital
Locked
Locked
Locked Nov 07 2024
Analyst Rating Date
Locked
Jones Trading:
Locked
Locked
Mar 12 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Mar 10 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Jan 23 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Jan 22 2025
Locked
RBC Capital:
Locked
Locked
Jan 07 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Jan 06 2025
Locked
RBC Capital:
Locked
Locked
Nov 07 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today